Brief: Viatris And Theravance Biopharma Announce Positive Top-Line Results From Yupelri (Revefenacin) Phase III Trial

Theravance Biopharma

13/11/2023 14:57

Nov 13 (Reuters) - Theravance Biopharma Inc  TBPH.O :
    * VIATRIS AND THERAVANCE BIOPHARMA ANNOUNCE POSITIVE
TOP-LINE
RESULTS FROM YUPELRI® (REVEFENACIN) PHASE III TRIAL IN CHINA FOR
THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Source text for Eikon:  ID:nPn98hCFha 
Further company coverage:  TBPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))